Turning Point Therapeutics Inc
(TPTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | NAMS | CNTA | ||
| Company | Turning Point Therapeutics Inc | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 34.26 | 23.60 | ||
| High | 76.01 | 35.62 | 24.35 | ||
| Low | 75.98 | 34.10 | 23.03 | ||
| Latest | 76.01 | 34.86 | 24.25 | ||
| Change | +0.52 | +0.62 | +0.69 | ||
| % Change | +0.69% | +1.81% | +2.93% | ||
| Volume | 2,843,300 | 444,000 | 1,606,200 | ||
| 20-Day Average Volume | 962,475 | 613,990 | 1,591,330 | ||
| Previous Close | 75.49 | 34.24 | 23.56 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 33.01 | 24.23 | ||
| 20-Day Raw Stochastic | 100.00% | 86.09% | 53.61% | ||
| 20-Day Relative Strength | 74.20 | 53.34 | 49.20 | ||
| Weighted Alpha | -18.70 | +89.16 | +24.14 | ||
| Today's Opinion | 96% Buy | 48% Buy | 40% Buy | ||
| Previous Opinion | 96% Buy | 16% Buy | 24% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +8.73% since 02/05/26 | +3.02% since 02/05/26 | ||
| Low | 74.86 on 08/10/22 | 32.15 on 02/06/26 | 22.50 on 02/11/26 | ||
| High | 76.01 on 08/16/22 | 35.62 on 02/12/26 | 24.55 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | +6.64% since 01/12/26 | +10.13% since 01/12/26 | ||
| Low | 74.57 on 07/21/22 | 30.17 on 01/20/26 | 21.50 on 01/20/26 | ||
| High | 76.01 on 08/16/22 | 35.62 on 02/12/26 | 26.63 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -9.01% since 11/12/25 | -9.18% since 11/12/25 | ||
| Low | 30.85 on 05/25/22 | 30.17 on 01/20/26 | 21.50 on 01/20/26 | ||
| High | 76.01 on 08/16/22 | 42.00 on 11/26/25 | 30.58 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +39.44% since 08/12/25 | +41.73% since 08/12/25 | ||
| Low | 23.77 on 03/15/22 | 23.05 on 09/15/25 | 15.01 on 09/03/25 | ||
| High | 76.01 on 08/16/22 | 42.00 on 11/26/25 | 30.58 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 3,952,810 | 3,259,710 | ||
| Shares Outstanding, K | 50,074 | 113,391 | 134,421 | ||
| Annual Sales | 30,830,000 | 45,560,000 | 0 | ||
| Annual Net Income | -236,550,000 | -241,600,000 | -235,760,000 | ||
| Last Quarter Sales | 120,000 | 350,000 | 0 | ||
| Last Quarter Net Income | -123,090,000 | -72,010,000 | -50,340,000 | ||
| 60-Month Beta | -0.18 | 0.06 | 1.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -0.41 on 11/05/25 | -0.41 on 11/05/25 | ||
| Latest Earnings Date | 11/08/22 | 02/25/26 | 03/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||